|  Despite
having been used widely for over 15 years, carboplatin and similar
drugs continue to inspire quite a bit of scientific research.
Single-dose
carboplatin as effective as radiation for early testicular cancer
Advanced
Cervical Cancer Can Be Successfully Downstaged With Pre-Surgery
Carboplatin And Docetaxel
Advances
in platinum chemotherapy from RSC
Pharmacologic
Study of Infusional Topotecan and Carboplatin in Relapsed and
Refractory Acute Leukemia
Cisplatin-
versus carboplatin-based chemotherapy in first-line treatment
of advanced non-small-cell lung cancer: an individual patient
data meta-analysis.
A
phase II trial of carboplatin for intraocular retinoblastoma.
Phase
I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel,
ABI-007 (Abraxane) on three treatment schedules in patients with
solid tumors.
Phase
I trial of the proteasome inhibitor bortezomib in combination
with carboplatin in patients with platinum- and taxane-resistant
ovarian cancer
Carboplatin
May Be Less Toxic Than Radiation for Seminoma - One shot of
carboplatin appeared to be as effective as radiation therapy in
treating early seminoma, a kind of testicular cancer, and also
appeared safer, reducing the risk of second cancers.
Clinical
trials involving carboplatin - from the NIH
Phase
I and pharmacodynamic trial of the DNA methyltransferase inhibitor
decitabine and carboplatin in solid tumors.
|
Carboplatin
What Is Carboplatin?